
bc

Shares in cannabis company Tilray up following U.K. supply deal with Grow Pharma

Cannabis company Tilray reports US$2.9 million loss on US$56.5M revenue in Q4

Vote by Tilray shareholders on Aphria merger deal delayed until April 30

Tilray-Aphria deal closes, company to control biggest share of Cdn pot market



